1.0Kuwait News Gazettehttps://kuwaitnewsgazette.comkgadminhttps://kuwaitnewsgazette.com/author/kgadmin/PHAT INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT - Kuwait News Gazetterich600338<blockquote class="wp-embedded-content" data-secret="RDUNgonSAV"><a href="https://kuwaitnewsgazette.com/phat-investor-notice-rosen-recognized-investor-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat/">PHAT INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://kuwaitnewsgazette.com/phat-investor-notice-rosen-recognized-investor-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat/embed/#?secret=RDUNgonSAV" width="600" height="338" title="“PHAT INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT” — Kuwait News Gazette" data-secret="RDUNgonSAV" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> NEW YORK, Jan. 11, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public. SO WHAT: If you […]https://ci3.googleusercontent.com/proxy/m467rbMmxw2KpWWSj0mGVTZCTcbBJjFsYPyG726mCvEqRs2rT9A8YtdG6BH6d6ZsivlSoJ2njiOXjA1Sponl106lnup2iCNH5qXZb941OT3i24qm2u3oZXviSe4wL_pLR7Fjsc_6nndfRinmUT4wdqgP5IWEedWdRM3DZlQz_Ll8T9hblm6q2Pu_w6OSJ79nKQ=s0-d-e1-ft#https://ml.globenewswire.com/media/OTgyZmJhZjktMDQyMC00NjQzLTgwZWYtYjg0OGQ4Mzg1MjVjLTEwMzE5ODM=/tiny/The-Rosen-Law-Firm-PA.png